Form 8-K - Current report:
SEC Accession No. 0000950170-25-067495
Filing Date
2025-05-09
Accepted
2025-05-09 07:05:23
Documents
13
Period of Report
2025-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bold-20250509.htm   iXBRL 8-K 46062
2 EX-99.1 bold-ex99_1.htm EX-99.1 111138
3 GRAPHIC img6362560_0.jpg GRAPHIC 106615
  Complete submission text file 0000950170-25-067495.txt   431224

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bold-20250509.xsd EX-101.SCH 25994
15 EXTRACTED XBRL INSTANCE DOCUMENT bold-20250509_htm.xml XML 4931
Mailing Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121
Business Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Filer) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41989 | Film No.: 25928335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)